SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001140361-24-023047
Filing Date
2024-04-29
Accepted
2024-04-29 16:45:10
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-29

Document Format Files

Seq Description Document Type Size
1 ARS ny20024296x4_ars.pdf ARS 880291
  Complete submission text file 0001140361-24-023047.txt   1213986
Mailing Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335
Business Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335 248-681-9815
Ocuphire Pharma, Inc. (Filer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-34079 | Film No.: 24891962
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)